EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolic reprogramming in cardiac fibrosis: mechanisms, crosstalk, and therapeutic interventions

Xiaoqian Wang, Xiaomei Wang, Fei Guo, Qian Ding, Honghua Jin

Frontiers in Physiology · 27.07.2026 · 17

DOI: 10.3389/fphys.2026.1811882 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Physiology, online erschienen am 27.07.2026. Verfasst von Xiaoqian Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Affiliated Hospital of Yanbian University (Yanbian Hospital), Yanbian University, Yanji, China. Die Arbeit nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac fibrosis is a pathological process accompanied by the development of cardiovascular diseases, which is mainly manifested as excessive deposition of extracellular matrix (ECM) of the heart muscle. Recent studies indicate that metabolic reprogramming significantly influences fibroblast activation, collagen deposition, and the fibrotic process by reshaping glycolytic, lipid, and amino acid metabolic pathways. This paper systematically reviews the mechanism of metabolic reprogramming in cardiac fibrosis and puts forward potential intervention strategies from a critical perspective. Although metabolic reprogramming shows potential in regulating cardiac fibrosis, its practical application still faces major challenges. Future research should strive to build a comprehensive research framework and promote metabolic reprogramming research to open a new way of precise intervention for the prevention and treatment of cardiac fibrosis through cross−technological innovation and precise regulation.

Schlagwörter

Stichwörter der Autor:innen

amino acid metabolismcardiac fibrosisglycolysislipid metabolismmetabolic reprogramming

Autor:innen und Institutionen

  • Department of Pharmacy, The Affiliated Hospital of Yanbian University (Yanbian Hospital), Yanbian University, Yanji, China.
  • College of Pharmacy, Yanbian University, Yanji, China.
  • Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, China.

Zitieren

APA

Wang, X., Wang, X., Guo, F., Ding, Q., & Jin, H. (2026). Metabolic reprogramming in cardiac fibrosis: mechanisms, crosstalk, and therapeutic interventions. Frontiers in Physiology, 17. https://doi.org/10.3389/fphys.2026.1811882

Vancouver

Wang X, Wang X, Guo F, Ding Q, Jin H. Metabolic reprogramming in cardiac fibrosis: mechanisms, crosstalk, and therapeutic interventions. Frontiers in Physiology. 2026;17. doi:10.3389/fphys.2026.1811882

BibTeX
@article{Wang2026,
  author = {Wang, Xiaoqian and Wang, Xiaomei and Guo, Fei and Ding, Qian and Jin, Honghua},
  title = {Metabolic reprogramming in cardiac fibrosis: mechanisms, crosstalk, and therapeutic interventions},
  journal = {Frontiers in Physiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphys.2026.1811882}
}
Kostenlos starten →